GTx, Inc. is a biopharmaceutical company, founded in 1997, dedicated to the development and commercialization of therapeutic products for men’s health. The company’s drug discovery and development programs focus on small molecules that selectively target and modulate nuclear hormone receptors for estrogens and androgens.